Noxopharm Ltd has released a press release.
Trading Halt
Filed with ASX ·
On 6ix: 6ix.com/news/trading-halt-855
6ix hasn’t read this filing yet.
Earlier from Noxopharm
- Pause in Trading
- Latest CRO-67 data shows success in reducing cancer growth
- Appendix 4E and Audited Financial Statements
- June 2023 Activities Report and Appendix 4C
- IONIC Trial Abstract Published at ASCO
Later from Noxopharm
- US FDA grants Orphan Drug Designation for CRO-67
- Response to ASX Query
- September 2023 Activities Report and Appendix 4C
- mRNA Vaccine Enhancer Shows Inflammation Reduction
- Noxopharm 2023 AGM Corporate Presentation
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm